Wispostatin-2

General Information


DRACP ID  DRACP05004

Peptide Name   Wispostatin-2

Sequence  TAWGPCSTTCGLGMATRV

Sequence Length  18

UniProt ID  Not available

PubChem CID  Not available

Origin  Homo sapiens (WISP-2)

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic 

Disulfide/Other Bond  Native peptide

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C75H122N22O24S3

Absent amino acids  DEFHIKNQY

Common amino acids  T

Mass  211552

Pl  8.23

Basic residues  1

Acidic residues  0

Hydrophobic residues  5

Net charge  1

Boman Index  -596

Hydrophobicity  37.22

Aliphatic Index  48.89

Half Life 
  Mammalian: 1.9 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  5625

Absorbance 280nm  330.88

Polar residues  10

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 18780781

Title  A systematic methodology for proteome-wide identification of peptides inhibiting the proliferation and migration of endothelial cells

Doi 10.1073/pnas.0803241105

Year  2008

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DRACP is developed by Dr.Zheng's team.